why choose us

First received: February 23, 2024

Clinical Trial: A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes Mellitus, Type 2

Study Type: INTERVENTIONAL


Official Title: Pharmacodynamic Properties of Insulin Icodec During Exercise and Prolonged Fasting in Participants With Type 2 Diabetes

Brief Summary: The study will investigate the safety of once weekly insulin icodec subcutaenously (s.c.) during and after exercise and prolonged fasting in patients with type 2 diabetes (T2D).Participants will first receive insulin decludec (Tresiba®, a long-acting insulin taken once daily) for atleast one week.Afterwards participants will receive insulin icodec that will be administered once weekly at the study site (for a minimum of 7 weeks and maximum of 14 weeks).Insulin icodec is a novel long-acting insulin analogue for…

Read more